Exocytosis is a fundamental process used by eukaryotes to regulate the composition of the plasma membrane and facilitate cell-cell communication. To

Ellen C. O'Shaughnessy; Mable Lam; Samantha E. Ryken; Theresa Wiesner; Kimberly Lukasik; J. Bradley Zuchero; Christophe Leterrier; David Adalsteinsson; Stephanie L. Gupton. pHusion: A robust and versatile toolset for automated detection and analysis of exocytosis. Journal of Cell Science 2024 .

Ellen C. O'Shaughnessy, Mable Lam, Samantha E. Ryken, Theresa Wiesner, Kimberly Lukasik, J. Bradley Zuchero, Christophe Leterrier, David Adalsteinsson, Stephanie L. Gupton. pHusion: A robust and versatile toolset for automated detection and analysis of exocytosis. Journal of Cell Science. 2024; ():.

Ellen C. O'Shaughnessy; Mable Lam; Samantha E. Ryken; Theresa Wiesner; Kimberly Lukasik; J. Bradley Zuchero; Christophe Leterrier; David Adalsteinsson; Stephanie L. Gupton. 2024. "pHusion: A robust and versatile toolset for automated detection and analysis of exocytosis." Journal of Cell Science , no. : .

Julien Giacomoni; Jean-Marc Sabatier. Renin-Angiotensin System Dysregulation: ADAM17 Activation Conse-quences Related to SARS-CoV-2. Infectious Disorders - Drug Targets 2024, 24, 1 -2.

Julien Giacomoni, Jean-Marc Sabatier. Renin-Angiotensin System Dysregulation: ADAM17 Activation Conse-quences Related to SARS-CoV-2. Infectious Disorders - Drug Targets. 2024; 24 ():1-2.

Julien Giacomoni; Jean-Marc Sabatier. 2024. "Renin-Angiotensin System Dysregulation: ADAM17 Activation Conse-quences Related to SARS-CoV-2." Infectious Disorders - Drug Targets 24, no. : 1-2.

Julien Giacomoni; Jean-Marc Sabatier. Vitamin D and Mitochondrial Activity Preservation in COVID-19. Infectious Disorders - Drug Targets 2024, 24, 1 -3.

Julien Giacomoni, Jean-Marc Sabatier. Vitamin D and Mitochondrial Activity Preservation in COVID-19. Infectious Disorders - Drug Targets. 2024; 24 ():1-3.

Julien Giacomoni; Jean-Marc Sabatier. 2024. "Vitamin D and Mitochondrial Activity Preservation in COVID-19." Infectious Disorders - Drug Targets 24, no. : 1-3.